“While I was pleased to receive assurances that the agency will, in the coming weeks, deliver a long overdue decision on Plan B, concerns about Dr. Crawford’s leadership remain,” Murray said in a statement. “I have been continually concerned during Dr. Crawford’s tenure that FDA hasn’t shown the independence and adherence to science necessary to inspire public confidence.” – (Full Article)
The Washington Post – July 19, 2005
Share
- July 19, 2005
English 
Spanish